Vinicius Silbiger De Stefano

20% fewer Medicare Part D claims than the average cornea and external diseases specialist physician in 2024

1,008 Medicare Part D claims for 225 beneficiaries, against an average of 1,263 among the 330 providers of this specialty who prescribed in Part D. Brand-name drugs were 29% of claims.

Most prescribed

1. Moxifloxacin266 claims
2. Prednisolone Acetate257 claims
3. Ketorolac Tromethamine207 claims
4. Erythromycin68 claims
5. Valacyclovir29 claims
6. Ofloxacin22 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 80.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $187.03

2 payments; by number, the most common kind was food and beverage; the largest payer was Bausch & Lomb Americas Inc. The 284 providers of this specialty with any payment received $3,109.37 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 2 group practices

1. Froedtert Andthe Medical College OF Wisconsin Community Physicians IncMequon, WI
2. The Medical College OF Wisconsin IncMilwaukee, WI

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).